Tag: Calidi Biotherapeutics Inc.

CLDI has 36-month beta value of 1.05. Analysts have mixed views on the stock, with 2 analysts rating it as a “buy,” 0 as “overweight,”

Company’s 36-month beta value is 1.15.Analysts have differing opinions on the stock, with 2 analysts rating it as a “buy,” 0 as “overweight,” 0 as

In the past week, CLDI stock has gone down by -0.82%, with a monthly gain of 35.36% and a quarterly plunge of -39.80%. The volatility